Inverse

An Understudied Psychedelic Could Be A Promising New Mental Health Treatment

Over the past two decades, researchers have published study after study evaluating the therapeutic potential of psychedelics like psilocybin and LSD. The research is so promising that despite being ...
Business Insider

XPhyto Therapeutics Corp. Featured in Syndicated Broadcast Covering Latest Progress Report on Mescaline Program for Psychedelic Therapies

VANCOUVER, British Columbia, June 15, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT), a bioscience accelerator focused on next-generation ...
Business Insider

XPhyto Provides Progress Report on Mescaline Program for Psychedelic Therapies

Research and development lab set up, preliminary mescaline synthesis complete Modified synthesis process developed, mescaline batches manufactured Development of analytical methods and validation, GMP ...
Business Wire

Biomind Labs to Commence Commercial Clinical Trial on Its Proprietary Mescaline Candidate BMND06

TORONTO--(BUSINESS WIRE)--Biomind Labs Inc. (“Biomind Labs” or the “Company”) (NEO: BMND) (OTC: BMNDF) (FSE: 3XI), a leading biotech company developing the next generation of pharmaceuticals to treat ...